Deutsche Bank AG grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 9.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,522,191 shares of the medical equipment provider’s stock after purchasing an additional 132,966 shares during the quarter. Deutsche Bank AG’s holdings in Intuitive Surgical were worth $862,108,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in ISRG. Brighton Jones LLC grew its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Sivia Capital Partners LLC grew its position in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the last quarter. Schnieders Capital Management LLC. grew its position in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after buying an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $200,000. Finally, Main Street Financial Solutions LLC grew its position in shares of Intuitive Surgical by 92.4% during the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after buying an additional 1,407 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Intuitive Surgical
In related news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction that occurred on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,698 shares of company stock valued at $2,859,708 over the last ninety days. Insiders own 0.60% of the company’s stock.
Key Headlines Impacting Intuitive Surgical
- Positive Sentiment: Intuitive Surgical was upgraded to Zacks Rank #2 (Buy), which signals improved earnings expectations and may support the stock in the near term. Article: Intuitive Surgical (ISRG) Upgraded to Buy: Here’s Why
- Positive Sentiment: Another note said ISRG can expand margins through scale, cost discipline, and adoption of the da Vinci 5 system, helping offset tariff and inflation pressures. Article: Will ISRG’s Cost Leverage Aid Margins Amid Tariff & Input Inflation?
- Neutral Sentiment: Analysts reset their fair value estimate lower, from $611.82 to $565.25, reflecting a more cautious valuation view even while long-term growth optimism remains intact. Article: How The Intuitive Surgical (ISRG) Narrative Is Shifting With Reset Valuations And Mixed Analyst Views
- Neutral Sentiment: Coverage also noted that Medtronic is still trying to challenge Intuitive Surgical’s dominance in robotic surgery, keeping competitive pressure in view. Article: Can Medtronic Finally Challenge Intuitive Surgical’s Robotic Surgical Systems Dominance?
Intuitive Surgical Trading Up 1.9%
Shares of NASDAQ:ISRG opened at $426.61 on Wednesday. The company has a 50 day moving average of $445.72 and a 200-day moving average of $498.83. The firm has a market cap of $151.09 billion, a P/E ratio of 51.71, a P/E/G ratio of 3.34 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same period in the prior year, the business earned $1.81 earnings per share. The business’s quarterly revenue was up 23.0% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.
Analyst Ratings Changes
A number of brokerages recently weighed in on ISRG. Mizuho set a $525.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Piper Sandler reaffirmed an “overweight” rating and set a $580.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. Bank of America lowered their price objective on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a research report on Monday, May 18th. UBS Group lowered their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Finally, TD Cowen lowered their price objective on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $573.63.
Read Our Latest Stock Report on ISRG
Intuitive Surgical Company Profile
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
